Contact
BioPharmX
  • About
    • Company
    • Management Team
    • Board of Directors
    • Advisory Boards
    • Special Advisory Council
    • Careers
  • Technology
    • HyantX™ Delivery System
  • Pipeline
    • Overview
    • BPX-01
    • BPX-04
    • Preclinical & Research
    • Posters
  • Investors
    • Overview
    • Corporate Governance
    • Financial Information
    • SEC Filings
    • News Releases
    • Events
    • FAQs
    • Alerts
  • Newsroom
    • Contact Us
    • In the News
    • Resources
    • Press Releases

Letter from the CEO

Dear BioPharmX Shareholders, I would like to introduce myself as the new CEO of BioPharmX. I was recruited by the Board of Directors because of my...

OUR DERMATOLOGY PIPELINE

We are growing our drug delivery platform portfolio to uncover innovative solutions in dermatology.

DISCOVER THE HYANTX™ DELIVERY SYSTEM

Our proprietary topical drug delivery system uses an anhydrous, hydrophilic technology that is suitable for multiple APIs.

INVESTOR RESOURCES

Our stock is listed on the NYSE American under the ticker symbol BPMX. View our latest investor presentation.

  • About
    • Company
    • Management Team
    • Board of Directors
    • Advisory Boards
    • Special Advisory Council
    • Careers
  • Technology
    • HyantX™ Delivery System
  • Pipeline
    • Overview
    • BPX-01
    • BPX-04
    • Preclinical & Research
    • Posters
  • Investors
    • Overview
    • Corporate Governance
    • Financial Information
    • SEC Filings
    • News Releases
    • Events
    • FAQs
    • Alerts
  • Newsroom
    • Contact Us
    • In the News
    • Resources
    • Press Releases
  • Home
  • Terms of Service
  • Privacy Policy
  • Site Map
LinkedIn Twitter Facebook

115 Nicholson Lane,
San Jose, CA 95134

650.889.5020650.889.5020

© 2020 BioPharmX, Inc. All rights reserved. BioPharmX is a trademark of BioPharmX, Inc. in the United States and other countries.